Ian Michael Estepan
President & COOMr. Ian Michael Estepan has been President and Chief Operating Officer of Sarepta Therapeutics, Inc. since July 2025 and served as its Executive Vice President and Chief Financial Officer since December 14, 2020 until July 2025. Mr. Estepan was Chief of Staff at Sarepta Therapeutics, Inc., from January 2018 to December 14, 2020 and was its Senior Vice President of Corporate Affairs from February 2019 to December 14, 2020. Mr. Estepan joined Sarepta Therapeutics, Inc. in January 2015 as Senior Director of Corporate Affairs and from October 2016 to December 2017, he served as Executive Director of Corporate Affairs. He had been Vice President of Corporate Affairs at Sarepta Therapeutics, Inc. since 2018. Mr. Estepan has been a Director at Cellarity, Inc. since December 2021. Mr. Estepan has experience in healthcare investing to fund the development of promising drug candidates in a diverse number of therapeutic areas. Over the past 5 years, he has combined his financial and clinical acumen to speed clinical development and patient access to new therapies for patients with Duchenne muscular dystrophy. Prior to joining Sarepta, from August 2001 to December 2014, Mr. Estepan was a senior portfolio manager for Wall Street’s Spectra Financial Group, where he was responsible for managing a multi-million dollar long-short portfolio of biotech, medtech and pharmaceutical stocks. Mr. Estepan began his career as a financial analyst for Salomon Smith Barney in June 1999, participating in multi-billion dollar deals and creating financial models for the number-one ranked health care group in investment banking. From December 1999 to May 2001, Mr. Estepan served as director of strategic planning at The MusicBooth LLC, where he managed all aspects of patented, internet-based, technology start-up, serving the 20 billion audio advertising industry. Mr. Estepan earned a Bachelor of Arts degree in psychology with a concentration in pre-medicine from Columbia University where he graduated Magna Cum Laude.
Positions
- Company NameSarepta Therapeutics, Inc.Stock CodeSRPTPositionPresident & COOColleagues
- MKM. Kathleen Behrens WilseyIndependent Chairwoman
- RHRyan H. WongExecutive VP & CFO
- CLCristin L. RothfussExecutive VP, General Counsel & Company Secretary
- DSDouglas S. IngramAdvisor
- LRLouise R. Rodino-KlapacPresident of Research & Development and Technical Operations
- MEMichael E. SeverinoCEO & Director
- HWHans WigzellChairman of Corporate Strategy Board & Independent Non-Employee Director
- RJRichard Jon BarryIndependent Director
- DPDeirdre P. ConnellyIndependent Director
